Plasma‐derived extracellular vesicles (EVs) as biomarkers of sepsis in burn patients via label‐free Raman spectroscopy
Sepsis following burn trauma is a global complication with high mortality, with ∼60% of burn patient deaths resulting from infectious complications. Diagnosing sepsis is complicated by confounding clinical manifestations of the burn injury, and current biomarkers lack the sensitivity and specificity required for prompt treatment. There is a strong rationale to assess circulating extracellular vesicles (EVs) from patient liquid biopsy as sepsis biomarkers due to their release by pathogens from bacterial biofilms and roles in the subsequent immune response. This study applies Raman spectroscopy to patient plasma-derived EVs for rapid, sensitive, and specific detection of sepsis in burn patients, achieving 97.5% sensitivity and 90.0% specificity. Furthermore, spectral differences between septic and non-septic burn patient EVs could be traced to specific glycoconjugates of bacterial strains associated with sepsis morbidity. This work illustrates the potential application of EVs as biomarkers in clinical burn trauma care and establishes Raman analysis as a fast, label-free method to specifically identify features of bacterial EVs relevant to infection amongst the host background.
Authors
- Hannah J. O’Toole (ORCID: https://orcid.org/0000-0002-1843-9332)
- Tina L. Palmieri (ORCID: https://orcid.org/0000-0001-6340-1715)
- Randy P. Carney (ORCID: https://orcid.org/0000-0001-8193-1664)
- Vishalakshi Arun
- Nam K. Tran (ORCID: https://orcid.org/0000-0003-1565-0025)
- Neona Lowe
- Anna V. Kolesov (ORCID: https://orcid.org/0009-0006-3870-7644)
Institutions
- Shriners Hospitals for Children - Northern California (US)
- Burn Institute (US)
- University of California, Davis (US)
Publication Details
- Journal
- Journal of Extracellular Vesicles
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/jev2.12506
- Citations
- 13
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- National Institutes of Health
- National Cancer Institute